Bristol-Myers Squibb
BMY
#175
Rank
S$163.16 B
Marketcap
S$79.82
Share price
1.78%
Change (1 day)
33.23%
Change (1 year)

EPS for Bristol-Myers Squibb (BMY)

EPS in 2026 (TTM): S$5.85

According to Bristol-Myers Squibb's latest financial reports the company's current EPS (TTM) is S$5.80. In 2025 the company made an earnings per share (EPS) of S$4.42 an increase over its 2024 EPS that were of S-$5.65.

EPS history for Bristol-Myers Squibb from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)S$5.8532.4%
2025S$4.42-178.28%
2024S-$5.65-213.92%
2023S$4.9630.2%
2022S$3.81-6.04%
2021S$4.05-179.29%
2020S-$5.11-281.37%
2019S$2.82-27.21%
2018S$3.87
2016S$3.41175.26%
2015S$1.24-19.83%
2014S$1.55-22.44%
2013S$1.9934.48%
2012S$1.48

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
S$11.16 92.37%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$8.51 46.70%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
S$0.97-83.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$4.56-21.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$38.18 558.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$20.72 257.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$2.43-58.09%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
S$7.26 25.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$1.62-72.12%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$8.53 47.14%๐Ÿ‡ฌ๐Ÿ‡ง UK